BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25686113)

  • 1. Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.
    Mangano A; Lianos GD; Mangano A; Boni L; Dionigi G
    Future Oncol; 2015; 11(4):561-4. PubMed ID: 25686113
    [No Abstract]   [Full Text] [Related]  

  • 2. Adapting clinical paradigms to the challenges of cancer clonal evolution.
    Murugaesu N; Chew SK; Swanton C
    Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
    Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
    OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor heterogeneity: nature and biological significance.
    Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
    Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
    Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
    Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Back to the beginning: The initiation of cancer.
    Cobaleda C; Sánchez-García I
    Bioessays; 2013 May; 35(5):413. PubMed ID: 23553938
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical implications of intratumor heterogeneity: challenges and opportunities.
    Ramón Y Cajal S; Sesé M; Capdevila C; Aasen T; De Mattos-Arruda L; Diaz-Cano SJ; Hernández-Losa J; Castellví J
    J Mol Med (Berl); 2020 Feb; 98(2):161-177. PubMed ID: 31970428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumor heterogeneity in evolutionary models of tumor progression.
    Durrett R; Foo J; Leder K; Mayberry J; Michor F
    Genetics; 2011 Jun; 188(2):461-77. PubMed ID: 21406679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for cancer vulnerabilities amid genetic chaos.
    Speicher MR
    Genome Biol; 2017 Aug; 18(1):147. PubMed ID: 28768521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stochastic gene expression stabilization as a new therapeutic strategy for cancer.
    Capp JP
    Bioessays; 2012 Mar; 34(3):170-3. PubMed ID: 22231918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumor heterogeneity in epigenetic patterns.
    Assenov Y; Brocks D; Gerhäuser C
    Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.
    Balluff B; Hanselmann M; Heeren RM
    Adv Cancer Res; 2017; 134():201-230. PubMed ID: 28110651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Evolutionary Principles: How Intratumor Heterogeneity Influences Cancer Treatment and Outcome.
    Venkatesan S; Swanton C
    Am Soc Clin Oncol Educ Book; 2016; 35():e141-9. PubMed ID: 27249716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of intertumor and intratumor heterogeneity in liver cancer.
    Liu J; Dang H; Wang XW
    Exp Mol Med; 2018 Jan; 50(1):e416. PubMed ID: 29303512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic basis of the Warburg effect.
    Wang X; Jin H
    Epigenetics; 2010 Oct; 5(7):566-8. PubMed ID: 20622527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 19. The tumor microenvironment and cancer.
    Chen Z; Meng Z; Jia L; Cui R
    Biomed Res Int; 2014; 2014():573947. PubMed ID: 25587537
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug resistance, epigenetics, and tumor cell heterogeneity.
    Hoey T
    Sci Transl Med; 2010 Apr; 2(28):28ps19. PubMed ID: 20410528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.